MX2012000680A - Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)-7,12,25-trioxa-1 9,21,24-triaza-tetraciclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2 ,4,9,14,16,18(26),20,22-nonaeno. - Google Patents
Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)-7,12,25-trioxa-1 9,21,24-triaza-tetraciclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2 ,4,9,14,16,18(26),20,22-nonaeno.Info
- Publication number
- MX2012000680A MX2012000680A MX2012000680A MX2012000680A MX2012000680A MX 2012000680 A MX2012000680 A MX 2012000680A MX 2012000680 A MX2012000680 A MX 2012000680A MX 2012000680 A MX2012000680 A MX 2012000680A MX 2012000680 A MX2012000680 A MX 2012000680A
- Authority
- MX
- Mexico
- Prior art keywords
- citrate salt
- nonaene
- hexacosa
- trioxa
- tetracyclo
- Prior art date
Links
- 150000001860 citric acid derivatives Chemical class 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22560909P | 2009-07-15 | 2009-07-15 | |
| PCT/SG2010/000265 WO2011008172A1 (en) | 2009-07-15 | 2010-07-14 | 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012000680A true MX2012000680A (es) | 2012-02-28 |
Family
ID=42790728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012000680A MX2012000680A (es) | 2009-07-15 | 2010-07-14 | Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)-7,12,25-trioxa-1 9,21,24-triaza-tetraciclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2 ,4,9,14,16,18(26),20,22-nonaeno. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9062074B2 (enExample) |
| EP (1) | EP2454266B1 (enExample) |
| JP (2) | JP6013911B2 (enExample) |
| CN (1) | CN102762577B (enExample) |
| AR (2) | AR077483A1 (enExample) |
| BR (1) | BR112012000750B1 (enExample) |
| CA (1) | CA2768210C (enExample) |
| DK (1) | DK2454266T3 (enExample) |
| ES (1) | ES2429525T3 (enExample) |
| HR (1) | HRP20130941T1 (enExample) |
| MX (1) | MX2012000680A (enExample) |
| PL (1) | PL2454266T3 (enExample) |
| PT (1) | PT2454266E (enExample) |
| RU (1) | RU2543721C2 (enExample) |
| SI (1) | SI2454266T1 (enExample) |
| SM (1) | SMT201300112B (enExample) |
| TW (1) | TWI537276B (enExample) |
| WO (1) | WO2011008172A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2017112748A (ru) | 2014-11-17 | 2018-12-19 | Арно Терапьютикс, Инк. | Композиции онапристона пролонгированного действия и способы |
| AU2016326657B2 (en) | 2015-09-25 | 2019-10-24 | Context Biopharma, Inc. | Methods of making onapristone intermediates |
| HK1255104A1 (zh) | 2015-12-15 | 2019-08-02 | Context Biopharma Inc. | 无定形的奥那司酮组合物及其制备方法 |
| WO2018102369A1 (en) | 2016-11-30 | 2018-06-07 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
| US7151096B2 (en) | 2003-03-05 | 2006-12-19 | Irm Llc | Cyclic compounds and compositions as protein kinase inhibitors |
| CN101360751B (zh) * | 2005-11-16 | 2011-09-14 | S*Bio私人有限公司 | 氧连接的嘧啶衍生物 |
-
2010
- 2010-07-14 BR BR112012000750-5A patent/BR112012000750B1/pt not_active IP Right Cessation
- 2010-07-14 JP JP2012520571A patent/JP6013911B2/ja active Active
- 2010-07-14 MX MX2012000680A patent/MX2012000680A/es active IP Right Grant
- 2010-07-14 CA CA2768210A patent/CA2768210C/en active Active
- 2010-07-14 EP EP10737645.1A patent/EP2454266B1/en active Active
- 2010-07-14 WO PCT/SG2010/000265 patent/WO2011008172A1/en not_active Ceased
- 2010-07-14 PT PT107376451T patent/PT2454266E/pt unknown
- 2010-07-14 US US13/384,139 patent/US9062074B2/en active Active
- 2010-07-14 CN CN201080032627.5A patent/CN102762577B/zh active Active
- 2010-07-14 RU RU2012105044/04A patent/RU2543721C2/ru active
- 2010-07-14 PL PL10737645T patent/PL2454266T3/pl unknown
- 2010-07-14 HR HRP20130941AT patent/HRP20130941T1/hr unknown
- 2010-07-14 SI SI201030347T patent/SI2454266T1/sl unknown
- 2010-07-14 ES ES10737645T patent/ES2429525T3/es active Active
- 2010-07-14 DK DK10737645.1T patent/DK2454266T3/da active
- 2010-07-15 TW TW099123331A patent/TWI537276B/zh active
- 2010-07-15 AR ARP100102594A patent/AR077483A1/es not_active Application Discontinuation
-
2013
- 2013-10-04 SM SM201300112T patent/SMT201300112B/xx unknown
-
2015
- 2015-05-07 JP JP2015094972A patent/JP2015164941A/ja active Pending
-
2019
- 2019-08-05 AR ARP190102219A patent/AR114987A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2429525T3 (es) | 2013-11-15 |
| HRP20130941T1 (hr) | 2013-11-08 |
| BR112012000750A2 (pt) | 2016-08-09 |
| PT2454266E (pt) | 2013-10-10 |
| DK2454266T3 (da) | 2013-09-08 |
| PL2454266T3 (pl) | 2014-01-31 |
| EP2454266B1 (en) | 2013-07-10 |
| BR112012000750A8 (pt) | 2018-02-06 |
| RU2543721C2 (ru) | 2015-03-10 |
| HK1178159A1 (en) | 2013-09-06 |
| BR112012000750B1 (pt) | 2021-05-25 |
| CA2768210A1 (en) | 2011-01-20 |
| US20120196876A1 (en) | 2012-08-02 |
| AR077483A1 (es) | 2011-08-31 |
| WO2011008172A1 (en) | 2011-01-20 |
| JP6013911B2 (ja) | 2016-10-25 |
| EP2454266A1 (en) | 2012-05-23 |
| CA2768210C (en) | 2017-08-15 |
| TW201107336A (en) | 2011-03-01 |
| SI2454266T1 (sl) | 2013-10-30 |
| SMT201300112B (it) | 2013-11-08 |
| AR114987A2 (es) | 2020-11-11 |
| JP2015164941A (ja) | 2015-09-17 |
| CN102762577A (zh) | 2012-10-31 |
| US9062074B2 (en) | 2015-06-23 |
| JP2012533539A (ja) | 2012-12-27 |
| TWI537276B (zh) | 2016-06-11 |
| CN102762577B (zh) | 2015-01-07 |
| RU2012105044A (ru) | 2013-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500872A1 (en) | Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| IN2012DN01233A (enExample) | ||
| NZ708928A (en) | Mannose derivatives for treating bacterial infections | |
| TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
| PH12012502142A1 (en) | Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities | |
| SG178952A1 (en) | Chemical compounds | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
| PH12013500238B1 (en) | N-acylsulfonamide apoptosis promoters | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| WO2011044506A3 (en) | Sulphone compounds for use in the treatment of obesity | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| EP2431366A4 (en) | NEW CONJUGATED CHLORINE E6 FOLIC ACID COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOUNDS THEREOF FOR THE TREATMENT OF CANCER | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| PH12012500622A1 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| MX2013011589A (es) | Metodos y composiciones para tratar enfermedad de parkinson. | |
| GB201304501D0 (en) | Liquid pharmaceutical compositions | |
| MX2013008340A (es) | Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer. | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| MX340147B (es) | Composiciones farmacéuticas y nutracéuticas del ácido abscísico. | |
| MX2013002208A (es) | Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
| PT2454266E (pt) | Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)- 7,12,25-trioxa-19,21,24-triaza-tetraciclo- [18.3.1.1(2,5).1(14)18)]hexacosa- 1(24),2,4,9,14,16,18(26),20,22-nonaeno | |
| MY160005A (en) | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | |
| WO2010093615A3 (en) | Compounds, their syntheses, compositions, and methods to treat cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: CTI BIOPHARMA CORP. |
|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |
Owner name: CTI BIOPHARMA CORP. |